Background: When resection is not an option, platinum-based chemoradiotherapy (CRT) has been the historic standard of care in non-small cell lung cancer (NSCLC). Prognosis remains poor with CRT alone. Durvalumab has shown significant improvement (versus placebo) in progression-free and overall...

Purpose: To explore receptivity of and preferences for risk-reducing health behavior changes among African American survivors of early-stage lung cancer and their family members. Participants & Setting: 26 African American non-small cell lung cancer survivor–family member dyads were recruited...

Problem Identification: Improving quality of life (QOL) is a key issue for patients with lung cancer. Exercise interventions could positively affect patients’ QOL; however, there is no clear-cut understanding of the role of exercise in improving QOL in patients with lung cancer. Literature Search:...